How do we address treating the negative symptoms of schizophrenia pharmacologically?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How do we address treating the negative symptoms of schizophrenia pharmacologically?

Published:2021-06-16 Issue:14 Volume:22 Page:1811-1813
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Kantrowitz Joshua T.¹²³^ORCID

Affiliation:

1. Division of Experimental Therapeutics, New York State Psychiatric Institute, New York, NY, USA

2. Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA

3. Schizophrenia Research Center, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1939677

Reference15 articles.

1. Managing Negative Symptoms of Schizophrenia: How Far Have We Come?

2. EPA guidance on assessment of negative symptoms in schizophrenia

3. Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development

4. EPA guidance on treatment of negative symptoms in schizophrenia

5. Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salivary Galectin 3 Levels in Schizophrenia Patients;Journal of the College of Physicians and Surgeons Pakistan;2024-02-01

2. New Developments in the Treatment of Schizophrenia: An Expert Roundtable;International Journal of Neuropsychopharmacology;2023-03-18

3. Challenges and Strategies for the Recruitment of Patients With Schizophrenia in a Research Setting;International Journal of Neuropsychopharmacology;2022-08-29

4. Recovering quality of life in outpatients with psychosis spectrum disorders and its association with the symptom domains;Medicinska istrazivanja;2022

5. The Latent Structure of Negative Symptoms in the General Population in Adolescence and Emerging Adulthood;Schizophrenia Bulletin Open;2022-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3